Non-cardiac Chest Pain Clinical Trial
— IKSITOfficial title:
Internet-delivered Cognitive Behavioral Therapy for Treatment of Cardiac Anxiety in Patients With Non-cardiac Chest Pain - a Randomized Controlled Study
Verified date | March 2023 |
Source | Linkoeping University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Non-cardiac chest pain (NCCP) is common and has substantial impact on patients' psychological wellbeing, quality of life and healthcare use. Although cardiac diagnosis is 'ruled out', many patients think they have an undetected cardiac disease (i.e. they suffer cardiac anxiety) as no other explanation is offered. They therefore avoid activities that they believe might be harmful to their heart, leading to greater ill-health, and increased healthcare use and societal costs. Targeting cardiac anxiety with psychological interventions might break this vicious circle and improve patient outcomes. Patients need to evaluate the way they perceive and handle their chest pain, which can be done with cognitive behavioral therapy (CBT). The aim of this study is therefore to evaluate the short- and long-term effects of an Internet-delivered CBT (I-CBT) program on psychological distress and other patient-reported outcomes in patients with NCCP. A second aim is to explore factors related to implementation of I-CBT in clinical care. The study has a randomized controlled design comparing I-CBT with Internet-delivered information program. Quantitative methods will be used to evaluate the effectiveness of the I-CBT program. Implementation issues will be evaluated from the perspectives of patients, healthcare professionals and policymakers using qualitative methods.
Status | Completed |
Enrollment | 109 |
Est. completion date | July 31, 2021 |
Est. primary completion date | October 9, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - at least 2 healthcare visits due to NCCP during the last 6 months - patients suffering from cardiac anxiety (score = 24 on the Cardiac Anxiety Questionnaire-CAQ) Exclusion Criteria: - language difficulties - not able to perform physical activity/exercise due to physical constraints - patients with severe depressive symptoms - patients with acute ischemic heart disease - patients with no access to computer/tablet and/or Internet |
Country | Name | City | State |
---|---|---|---|
Sweden | Linköping University | Linköping |
Lead Sponsor | Collaborator |
---|---|
Linkoeping University | Ostergotland County Council, Sweden |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cardiac anxiety | Cardiac Anxiety Questionnaire (CAQ) will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes related to intervention. The CAQ consists of 18 items and a score range between 0 and 72. The higher scores the greater cardiac anxiety. | 12 months after end of intervention | |
Secondary | Fear of body sensations | Body Sensations Questionnaire will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes related to intervention. The questionnaire comprises 17 items with scores ranging between 17 and 85 and the higher scores the greater fear of body sensations. | 12 months after end of intervention | |
Secondary | Depressive symptoms | Patient Health Questionnaire-9 will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes related to intervention. This questionnaire comprises 9 items with scores ranging between 0 and 27. Higher scores indicate higher levels of depressive symptoms. A cut-off of 10 demonstrates moderate levels and will be used in this study. | 12 months after end of intervention | |
Secondary | Health-related quality of life | EuroQol-5D (EQ-5D) will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes related to intervention. The EQ-5D includes five dimensions of Health-related quality of life: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has five levels corresponding to: no problems, slight problems, moderate problems, severe problems and extreme problems/unable. The questionnaire also includes an EQ-VAS, which is a visual analogue scale ranging from 0 (worst health you can imagine) to 100 (best health you can imagine). | 12 months after end of intervention | |
Secondary | Chest pain frequency | Self-developed open questions will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes in chest pain related to intervention. | 12 months after end of intervention | |
Secondary | Healthcare use | Care Data Warehouse (Register), data will be collected 12 months after the end of the intervention to assess changes related to intervention. | 12 months after end of intervention | |
Secondary | Societal costs | Cost per patient register and Social Insurance Office register, data will be collected 12 months after the end of the intervention to assess changes related to intervention. | 12 months after end of intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00164801 -
Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP patientsChinese?
|
N/A | |
Recruiting |
NCT06136494 -
iCBT for Cardiac Anxiety in Patients With NCCP
|
N/A | |
Completed |
NCT00373828 -
Non-cardiac Chest Pain Evaluation and Treatment Study (CARPA) - Part 1: Diagnosis.
|
N/A | |
Completed |
NCT00476398 -
Evaluation of Patients With Non-cardiac Chest Pain
|
Phase 4 | |
Completed |
NCT00462241 -
Treatment Study Comparing Manual Treatment or Advice in Acute, Musculoskeletal Chest Pain
|
N/A | |
Terminated |
NCT00164814 -
The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients
|
N/A |